NCT07045012Not yet recruiting
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 1 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This cross-sectional study will include postmenopausal women under the age of 60 who visited the Physical Medicine and Rehabilitation outpatient clinic at Beylikdüzü State Hospital between June 25 and July 25, 2025. Participants must have undergone a bone mineral density (BMD) assessment within the past six months using Dual X-ray Absorptiometry (DXA). Both osteoporotic and non-osteoporotic patients will be enrolled. Sociodemographic data such as age, height, weight, and BMI will be recorded. Femoral neck and L1-L4 T-scores and BMD values will be obtained from existing DXA results. Information on osteoporosis treatment, presence of fecal incontinence, constipation, and medication use will be collected. In the second phase, sarcopenia will be assessed according to EWGSOP2 criteria using bioelectrical impedance analysis for skeletal muscle mass, handgrip strength, and the five-time sit-to-stand test. Differences between the osteoporotic and non-osteoporotic groups will be analyzed.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 52 (estimated)
- First submitted
- 22 Jun 2025
- Start date
- 25 Jun 2025
- Primary completion date
- 25 Jul 2025
- Lead sponsor
- Beylikduzu State Hospital
- Diseases
- Osteoporosis
- NCT number
- NCT07045012
What you commit to
- Study type: Observational
- Planned participants: 52
- From 25 Jun 2025 to the primary completion date, 25 Jul 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of medications that could affect study outcomes (e.g., corticosteroids, muscle relaxants, or medications influencing bone/muscle metabolism).
Other illness
- Presence of neuromuscular diseases that could cause muscle loss.
- History of infection, recent surgery, or trauma.
- Presence of psychiatric disorders.
- Cognitive impairment that could interfere with test performance or data reliability.
Other
- Refusal to participate in the study.
Who the study is looking for
- Women under 60 years of age who are postmenopausal.
- Patients with or without a diagnosis of osteoporosis:
- Osteoporosis group: T-score ≤ -2.5 in femoral neck or L1-L4 region. Control group: T-score ≥ -1.0 in femoral neck and L1-L4 region.
- -Patients who provide written informed consent to participate in the study.
Age in the registry: 50 years to 59 years · Sex: Female
This page is information, not medical advice. Discuss any trial with your doctor.